Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.

The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review

Dols, Annemiek, Sienaert, Pascal, van Gerven, Heleen, Schouws, Sigfried, Stevens, Anja, Kupka, Ralph, Stek, Max L. · 2013 · International Clinical Psychopharmacology

Abstract

Side effects are among the most frequent reasons preventing patients from taking their medication. Although the management of side effects is an important issue in clinical practice, particularly in patients with physical comorbidities, research on clinical management of side effects is rather scattered. The aim of this article was to provide an overview on the prevalence and management of various side effects of mood-stabilizing drugs. In December 2012, we carried out a PubMed search for publications reporting side effects in patients with bipolar disorder. Naturalistic studies describing the prevalence of side effects in treatment with mood stabilizers are sparse. We describe the prevalence of neurological, gastrointestinal, metabolic, thyroid, dermatological, nephrogenic, cognitive, sexual, hematological, hepatogenic, and teratogenic side effects of lithium, valproate, carbamazepine, and lamotrigine and discuss their clinical management. There are specific strategies that aim at reducing side effects, but, to date, studies on the efficacy of these interventions are lacking. With age, the renal elimination and hepatic metabolism of drugs reduce and comedication and somatic comorbidity increase, making elderly patients particularly susceptible to side effects. Most side effects can be managed by striving for the lowest possible dose without losing efficacy by lowering the dose below the therapeutic window. Specific measurements to limit certain side effects are available and may ameliorate treatment adherence.

Overview

Integrity signals

Registry

Crossref · 10.1097/yic.0b013e32836435e2

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 120 references

Cited by

See all 86

Metadata

Authors
Dols, A., Sienaert, P., van Gerven, H., Schouws, S., Stevens, A., Kupka, R., & Stek, M. L.
Affiliations
  • GGZ inGeest (NL)
  • KU Leuven (BE)
  • Dimence (NL)
Corresponding author
Dols, Annemiek
Venue
International Clinical Psychopharmacology
Published
2013-11
Volume
28
Issue
6
Pages
287-296
ISSN
0268-1315 (ISSN-L)
OpenAlex
W2043524592
Cited by
86
References
120
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 8 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 11 · 2016: 12 · 2015: 10 · 2014: 5 · 2013: 1
FWCI
6.61
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
bipolar disorder, mood stabilizers, lithium, antiepileptic drugs, valproic acid, carbamazepine, lamotrigine, adverse drug reactions, side effect management, dose reduction, medication adherence, elderly patients, renal excretion, hepatic metabolism, somatic comorbidity, teratogenicity, nephrogenic diabetes insipidus, thyroid dysfunction, hepatotoxicity, sexual dysfunction
MeSH terms
Anticonvulsants, Bipolar Disorder, Cognition Disorders, Gastrointestinal Diseases, Humans, Lithium, Prevalence, Antimanic Agents, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review. https://app.cochat.ai/papers/10.1097/yic.0b013e32836435e2
The paper
Dols, A., Sienaert, P., van Gerven, H., Schouws, S., Stevens, A., Kupka, R., & Stek, M. L. (2013). The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0b013e32836435e2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.